- Active not recruitingPHASE3
Phase III Study of AK112 for NSCLC Patients
This study looks at a new drug, AK112, combined with standard chemotherapy for a type of lung cancer. It's for people whose cancer has progressed after previous targeted treatment. We want to see if this combination gives better results than chemotherapy alone.
For: Non-Squamous Non-small Cell Lung CancerUnited States · Canada · France - RecruitingPHASE3
A Study Assessing the Effect of Dupilumab on Inducing Clinical Remission in Asthma
This study looks at whether a new asthma medicine, dupilumab, can help people with moderate asthma achieve full control earlier. It aims to prevent severe asthma by treating high-risk patients before their condition gets worse, potentially changing how asthma is managed.
For: Asthma ControlAustralia · Canada · United Kingdom - RecruitingNA
Platelet-rich Plasma in Symptomatic Knee Osteoarthritis
This study is looking at whether injections of Platelet-Rich Plasma (PRP) can help reduce pain in people with moderate knee osteoarthritis. We're comparing PRP to a 'dummy' injection (placebo) to see if it makes a real difference.
For: Knee OsteoarthritisFrance